FDA Device Regulators to Outline Obama Administration's Priorities at Elsevier Business Intelligence's 'IN3 East'

BOSTON, MA, Jun 16 (MARKET WIRE) --
Elsevier Business Intelligence announced today that two medical device
overseers from the FDA's Center for Devices and Radiological Health
(CDRH) will summarize the Obama administration's top priorities regarding
medical device regulation to kick-off 'IN3 East', the East Coast's
biggest annual strategic partnership and investment meeting for
senior-level medical technology executives, to be held June 24th and 25th
at The Westin Copley Place, Boston.

Heather S. Rosecrans, Director of CDRH 510(k) Staff, and Michael
Marcarelli, Director of the CDRH Division of Bioresearch Monitoring/Office
of Compliance, will participate in a panel discussion, "Working
Successfully with the FDA: Priorities Under the New Administration." The
panel will be moderated by Mary Houghton, Executive Editor of The Gray
Sheet. Published Weekly, The Gray Sheet provides in-depth specialized
coverage of the medical device, diagnostic and instrumentation
industries. The spectrum of coverage includes regulatory agency and
congressional activities, industry developments and investor/financial
news.

"Heather and Michael will help device companies understand the FDA's
current thinking on 510(k) clearance, and the CDRH's new program to
reclassify many medical devices," said Ms. Houghton. "In addition, Heather
and Michael will share the FDA's tips on ensuring data integrity in
clinical trials."

Hundreds of venture capital firms and medical technology companies are
expected to attend IN3 East on June 24th and 25th to hear about the latest
innovations and investment opportunities from more than 50 emerging
medical technology companies seeking funding and/or strategic
partnerships.

Prior to IN3 East, on June 23rd, senior executives from Becton Dickinson
(BD), Covidien, DePuy-Mitek/Johnson & Johnson, Integra LifeSciences Corp.,
Medtronic, Siemens Venture Capital, and Wright Medical Technology will
make individual presentations at Elsevier's Medtech Insight 'Medical
Device Investor Day', which also will be held at The Westin Copley Place,
Boston. "If you need to know which investment models of the big medtech
companies are working, then this is a must-attend conference," said David
Cassak, Managing Director for Medical Devices at Elsevier Business
Intelligence, who will moderate the Opening Keynote Panel Discussion:
'Larger Medical Technology Company M&A/Deal Trends.'

For more information about 'IN3 East' and 'Medical Device Investor Day',
visit www.medtechinsight.com, or contact Kristy Grimes at 480-985-9512,
888-290-2225 (U.S. toll-free), or email k.grimes@elsevier.com.

Contact:
Ronald Trahan, APR
Ronald Trahan Associates Inc.
508-359-4005, x108

Copyright 2009, Market Wire, All rights reserved.

-0-